|
Dr. Johnson joined Kereos as a Director in September of 2005 bringing with him over two decades of venture capital experience. Prior to joining Prolog, he was Vice President of Monsanto Venture Capital and Monsanto�s director of new ventures and technology where he oversaw Monsanto�s $80 million portfolio of corporate venture investments. Dr. Johnson also spent 14 years as a general partner at Gateway Associates, a St. Louis-based venture capital company with more than $180 million in total funds under management. Besides Kereos, he also sits on the Boards of Everest, Singulex, and Stereotaxis. Dr Johnson holds a doctoral degree in physics from the University of Rochester and a bachelor�s degree from MIT. | 